236 related articles for article (PubMed ID: 6441067)
1. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy.
Valentijn RM; Radl J; Haaijman JJ; Vermeer BJ; Weening JJ; Kauffmann RH; Daha MR; van Es LA
Kidney Int; 1984 Nov; 26(5):760-6. PubMed ID: 6441067
[TBL] [Abstract][Full Text] [Related]
2. IgA-associated glomerulonephritides: a study with monoclonal antibodies.
Rajaraman S; Goldblum RM; Cavallo T
Clin Immunol Immunopathol; 1986 Jun; 39(3):514-22. PubMed ID: 3698346
[TBL] [Abstract][Full Text] [Related]
3. Deposition of polymeric IgA1 in idiopathic mesangial IgA-glomerulonephritis.
Waldherr R; Seelig HP; Rambausek M; Andrassy K; Ritz E
Klin Wochenschr; 1983 Sep; 61(18):911-5. PubMed ID: 6415341
[TBL] [Abstract][Full Text] [Related]
4. A pathogenic role for secretory IgA in IgA nephropathy.
Oortwijn BD; van der Boog PJ; Roos A; van der Geest RN; de Fijter JW; Daha MR; van Kooten C
Kidney Int; 2006 Apr; 69(7):1131-8. PubMed ID: 16395264
[TBL] [Abstract][Full Text] [Related]
5. [Immunopathology of glomerulonephritis with mesangial IgA deposits].
Berthoux FC
Nephrologie; 1989; 10(4):169-74. PubMed ID: 2699007
[TBL] [Abstract][Full Text] [Related]
6. Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy.
Valentijn RM; Radl J; Haayman JJ; Vermeer BJ; Weening JJ; Kauffmann RH; Daha MR; van Es LA
Contrib Nephrol; 1984; 40():87-92. PubMed ID: 6499467
[No Abstract] [Full Text] [Related]
7. Immune characteristics of renal allograft donors with mesangial IgA deposition.
Wang Z; Zhang X; Han W; Yu G; Ying Z; Xu X; Wang M; Zhou X; Lv J; Zhang H
Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
[TBL] [Abstract][Full Text] [Related]
8. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.
van den Wall Bake AW; Daha MR; Haaijman JJ; Radl J; van der Ark A; van Es LA
Kidney Int; 1989 Jun; 35(6):1400-4. PubMed ID: 2770118
[TBL] [Abstract][Full Text] [Related]
9. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
10. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
11. Specificity of IgA antibodies in sera from patients with IgA nephropathy.
Yagame M
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):353-60. PubMed ID: 1635280
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
Czerkinsky C; Koopman WJ; Jackson S; Collins JE; Crago SS; Schrohenloher RE; Julian BA; Galla JH; Mestecky J
J Clin Invest; 1986 Jun; 77(6):1931-8. PubMed ID: 3711340
[TBL] [Abstract][Full Text] [Related]
13. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
Hisano S; Matsushita M; Fujita T; Endo Y; Takebayashi S
Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy: an update.
Julian BA; Novak J
Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):171-9. PubMed ID: 15202611
[TBL] [Abstract][Full Text] [Related]
15. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
[TBL] [Abstract][Full Text] [Related]
16. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
Suzuki S; Kobayashi H; Sato H; Arakawa M
Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
[TBL] [Abstract][Full Text] [Related]
18. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
[TBL] [Abstract][Full Text] [Related]
19. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
[TBL] [Abstract][Full Text] [Related]
20. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
